Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Deventer

Showing results (191-200 of 273) with videos related to

Pageof 28
Sort By:
Surgical Endoscopy|August 24, 2000
Laparoscopic-assisted vs. open ileocolic resection for Crohn's disease. A comparative studyW A Bemelman, J F Slors, M S Dunker, et al.
Molecular Therapy. Methods & Clinical Development|July 6, 2019
Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABsAnna Majowicz, Bart Nijmeijer, Margit H Lampen, et al.
Blood|October 7, 2000
Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokinesN P Juffermans, W A Paxton, P E Dekkers, et al.
AIDS (London, England)|January 1, 1993
Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infectionM H Godfried, T van der Poll, J Jansen, et al.
Blood|February 1, 1992
Effects on leukocytes after injection of tumor necrosis factor into healthy humansT van der Poll, S J van Deventer, C E Hack, et al.
The Journal of Gene Medicine|May 10, 2013
Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene deliveryAnna Majowicz, Piotr Maczuga, Karin L Kwikkers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzeesB Kuipers, T van der Poll, M Levi, et al.
Scandinavian Journal of Gastroenterology|November 26, 1998
Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's diseaseH M van Dullemen, G J Wolbink, P C Wever, et al.
Infection and Immunity|July 23, 1999
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannanN P Juffermans, A Verbon, S J van Deventer, et al.
Molecular Therapy. Methods & Clinical Development|November 19, 2019
AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and AstrocytesSonay Keskin, Cynthia C Brouwers, Marina Sogorb-Gonzalez, et al.
Pageof 28

Showing results (191-200 of 273) with videos related to

Sort By:
Pageof 28
Surgical Endoscopy|August 24, 2000
Laparoscopic-assisted vs. open ileocolic resection for Crohn's disease. A comparative studyW A Bemelman, J F Slors, M S Dunker, et al.
Molecular Therapy. Methods & Clinical Development|July 6, 2019
Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABsAnna Majowicz, Bart Nijmeijer, Margit H Lampen, et al.
Blood|October 7, 2000
Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokinesN P Juffermans, W A Paxton, P E Dekkers, et al.
AIDS (London, England)|January 1, 1993
Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infectionM H Godfried, T van der Poll, J Jansen, et al.
Blood|February 1, 1992
Effects on leukocytes after injection of tumor necrosis factor into healthy humansT van der Poll, S J van Deventer, C E Hack, et al.
The Journal of Gene Medicine|May 10, 2013
Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene deliveryAnna Majowicz, Piotr Maczuga, Karin L Kwikkers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzeesB Kuipers, T van der Poll, M Levi, et al.
Scandinavian Journal of Gastroenterology|November 26, 1998
Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's diseaseH M van Dullemen, G J Wolbink, P C Wever, et al.
Infection and Immunity|July 23, 1999
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannanN P Juffermans, A Verbon, S J van Deventer, et al.
Molecular Therapy. Methods & Clinical Development|November 19, 2019
AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and AstrocytesSonay Keskin, Cynthia C Brouwers, Marina Sogorb-Gonzalez, et al.
Pageof 28